Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Envoy Medical Inc (COCH)

Envoy Medical Inc (COCH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,786
  • Shares Outstanding, K 28,787
  • Annual Sales, $ 230 K
  • Annual Income, $ -20,800 K
  • EBIT $ -20 M
  • EBITDA $ -19 M
  • 60-Month Beta 2.08
  • Price/Sales 82.78
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.41
  • Most Recent Earnings $-0.26 on 03/23/26
  • Next Earnings Date 05/07/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Instruments

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.29
  • Growth Rate Est. (year over year) +344,582.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6200 +3.69%
on 03/27/26
0.9539 -32.60%
on 03/17/26
-0.0814 (-11.24%)
since 02/27/26
3-Month
0.3625 +77.35%
on 02/11/26
0.9539 -32.60%
on 03/17/26
-0.0871 (-11.93%)
since 12/26/25
52-Week
0.3625 +77.35%
on 02/11/26
1.9100 -66.34%
on 05/14/25
-0.7171 (-52.73%)
since 03/28/25

Most Recent Stories

More News
Envoy Medical Reports Full Year 2025 Financial Results

Received FDA approval to expand fully implanted Acclaim® Cochlear Implant Pivotal Clinical Trial to final stageStrengthened balance sheet by extinguishing $32 million in debtSubsequent to year-end, closed...

COCH : 0.6429 (-1.49%)
Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant

First Cochlear Implant Company to Announce Completed Enrollment of a U.S. Pivotal Clinical Trial for a Fully Implanted Cochlear Implant seeking FDA ApprovalWhite Bear Lake, Minnesota--(Newsfile Corp. -...

COCH : 0.6429 (-1.49%)
Envoy Medical Regains Compliance with Nasdaq Listing Requirement

White Bear Lake, Minnesota--(Newsfile Corp. - February 24, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions,...

COCH : 0.6429 (-1.49%)
Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space

White Bear Lake, Minnesota--(Newsfile Corp. - February 23, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions,...

COCH : 0.6429 (-1.49%)
Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial

Financing was led by new investor and top-tier healthcare fund Nantahala Capital and longtime Envoy Medical shareholder, billionaire Glen Taylor Closing of $30 million in gross proceeds in upsized offering,...

COCH : 0.6429 (-1.49%)
Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant

45 of 56 Patients Implanted; Enrollment Completion Anticipated by End of MarchWhite Bear Lake, Minnesota--(Newsfile Corp. - February 17, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or...

COCH : 0.6429 (-1.49%)
Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering

$30.0 million upfront with up to an additional $48.0 million of potential aggregate gross proceeds upon the exercise in full of milestone-linked warrants for cashOffering led by Nantahala Capital, with...

COCH : 0.6429 (-1.49%)
Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering

$30.0 million upfront with up to an additional $48.0 million of potential aggregate gross proceeds upon the exercise in full of milestone-linked warrants for cashWhite Bear Lake, Minnesota--(Newsfile Corp....

COCH : 0.6429 (-1.49%)
Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant

Enrollment momentum accelerates as Company advances toward full enrollmentWhite Bear Lake, Minnesota--(Newsfile Corp. - December 18, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the...

COCH : 0.6429 (-1.49%)
Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio

Patent strengthens Company's global intellectual property portfolio and reinforces the Company's commitment to establishing and protecting competitive advantagesWhite Bear Lake, Minnesota--(Newsfile Corp....

COCH : 0.6429 (-1.49%)

Business Summary

Envoy Medical Inc. is a medical technology company focused on fully implanted hearing devices. The company's primary device is the fully implanted Acclaim(R) cochlear implant. Envoy Medical Inc., formerly known as Anzu Special Acquisition Corp I, is headquartered in White Bear Lake, Minnesota.

See More

Key Turning Points

3rd Resistance Point 0.7050
2nd Resistance Point 0.6884
1st Resistance Point 0.6657
Last Price 0.6429
1st Support Level 0.6264
2nd Support Level 0.6098
3rd Support Level 0.5871

See More

52-Week High 1.9100
Fibonacci 61.8% 1.3189
Fibonacci 50% 1.1363
Fibonacci 38.2% 0.9536
Last Price 0.6429
52-Week Low 0.3625

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.